Recognition places pharmaceutical excipients leader among the top 5% of companies globally, highlighting progress in emissions reduction, responsible sourcing, and sustainable supply chain practices
Deal expands SPI Pharma’s manufacturing footprint in Germany, enhances pharmaceutical ingredient offerings, and reinforces focus on fast-growing digestive health market
The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand
Seasoned governance expert and board leader brings extensive experience in strategic oversight, risk management, and corporate governance across multiple sectors
New-generation platform enhances anatomical visualization, streamlines surgical workflows, and expands access to advanced navigation technology for ENT surgeons across Europe
The company will present 21 oral and poster presentations spanning investigational and approved therapies
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
Seasoned pharmaceutical marketing leader brings extensive experience in brand management, sales strategy, and digital engagement to the expanded leadership role
Premium CBD+THC-infused gummies target stress relief, relaxation, and sleep recovery
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
